Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of Outcomes of Radiofrequency Ablation of Lung Tumors
Sponsor: University of Pittsburgh
Summary
The purpose of this study is to assess short and long term outcomes after radiofrequency ablation (RFA) of pulmonary malignancies in patients who are not candidates for surgical resection. This study will evaluate the efficacy of RFA for the treatment of lung tumors by assessing its impact on local tumor control, progression free survival, overall survival, dyspnea score and quality of life (QOL).
Official title: A Prospective Study of Outcomes of Radiofrequency Ablation of Lung Tumors
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
72
Start Date
2003-09
Completion Date
2028-03
Last Updated
2026-04-14
Healthy Volunteers
No
Conditions
Interventions
Radiofrequency ablation of pulmonary malignancies
Radiofrequency ablation is an inpatient procedure typically requiring one overnight stay in the hospital.
Quality of life assessment
Quality of life assessment is administered prior to the Radiofrequency ablation procedure and every 3 months for 1 year following the procedure.
Assessment of pain
Pain scores are obtained prior to the procedure, daily X 7 starting on the day of surgery, and then every 3 months for 1 year.
Locations (1)
Hillman Cancer Center
Pittsburgh, Pennsylvania, United States